Control Bionics Limited (ASX:CBL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0620
+0.0020 (3.33%)
Sep 18, 2026, 12:05 PM AEST

Control Bionics Revenue

In the fiscal year ending June 30, 2026, Control Bionics had annual revenue of 4.77M AUD, down -22.43%. Control Bionics had revenue of 1.95M in the half year ending June 30, 2026, a decrease of -18.43%.

Revenue
4.77M
Revenue Growth
-22.43%
P/S Ratio
7.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
33.67M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20264.77M-1.38M-22.43%
Jun 30, 20256.14M794.13K14.84%
Jun 30, 20245.35M-291.61K-5.17%
Jun 30, 20235.64M1.14M25.33%
Jun 30, 20224.50M413.43K10.11%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Compumedics61.88M
Nova Eye Medical34.87M
Cyclopharm34.42M
CleanSpace Holdings19.82M
ImpediMed14.61M
CurveBeam AI8.67M
OncoSil Medical5.09M
Epiminder2.13M
Revenue Rankings